Task: Answer the multiple choice question.
Question: Which compound exhibits a -20.036% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cn1ncc(Cl)c1C(=O)NC1CCCC1
b Fc1ccc(N2CCN(Cc3cnc(N4CCOCC4)s3)CC2)cc1
Answer: b. Fc1ccc(N2CCN(Cc3cnc(N4CCOCC4)s3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccc(N2CCN(Cc3cnc(N4CCOCC4)s3)CC2)cc1
Fc1ccc(N2CCN(Cc3cnc(N4CCOCC4)s3)CC2)cc1
4-[5-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-1,3-thiazol-2-yl]morpholine